497 related articles for article (PubMed ID: 30388424)
1. PPM1D Mutations Drive Clonal Hematopoiesis in Response to Cytotoxic Chemotherapy.
Hsu JI; Dayaram T; Tovy A; De Braekeleer E; Jeong M; Wang F; Zhang J; Heffernan TP; Gera S; Kovacs JJ; Marszalek JR; Bristow C; Yan Y; Garcia-Manero G; Kantarjian H; Vassiliou G; Futreal PA; Donehower LA; Takahashi K; Goodell MA
Cell Stem Cell; 2018 Nov; 23(5):700-713.e6. PubMed ID: 30388424
[TBL] [Abstract][Full Text] [Related]
2. Protein phosphatase, Mg
Husby S; Hjermind Justesen E; Grønbæk K
Br J Haematol; 2021 Feb; 192(4):697-705. PubMed ID: 33616916
[TBL] [Abstract][Full Text] [Related]
3. Cellular stressors contribute to the expansion of hematopoietic clones of varying leukemic potential.
Wong TN; Miller CA; Jotte MRM; Bagegni N; Baty JD; Schmidt AP; Cashen AF; Duncavage EJ; Helton NM; Fiala M; Fulton RS; Heath SE; Janke M; Luber K; Westervelt P; Vij R; DiPersio JF; Welch JS; Graubert TA; Walter MJ; Ley TJ; Link DC
Nat Commun; 2018 Jan; 9(1):455. PubMed ID: 29386642
[TBL] [Abstract][Full Text] [Related]
4. PPM1D in Solid and Hematologic Malignancies: Friend and Foe?
Zhang L; Hsu JI; Goodell MA
Mol Cancer Res; 2022 Sep; 20(9):1365-1378. PubMed ID: 35657598
[TBL] [Abstract][Full Text] [Related]
5. Mutant
Singh A; Mencia-Trinchant N; Griffiths EA; Altahan A; Swaminathan M; Gupta M; Gravina M; Tajammal R; Faber MG; Yan L; Sinha E; Hassane DC; Hayes DN; Guzman ML; Iyer R; Wang ES; Thota S
JCO Precis Oncol; 2022 Jan; 6():e2100309. PubMed ID: 35025619
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of mutant PPM1D enhances DNA damage response and growth suppressive effects of ionizing radiation in diffuse intrinsic pontine glioma.
Akamandisa MP; Nie K; Nahta R; Hambardzumyan D; Castellino RC
Neuro Oncol; 2019 Jun; 21(6):786-799. PubMed ID: 30852603
[TBL] [Abstract][Full Text] [Related]
7. Potentiality of Protein phosphatase Mg
Yu M; Hu J; He D; Chen Q; Liu S; Zhu X; Li B
J Clin Lab Anal; 2020 May; 34(5):e23171. PubMed ID: 31901183
[TBL] [Abstract][Full Text] [Related]
8. Clonal hematopoiesis with
Stelmach P; Richter S; Sauer S; Fabre MA; Gu M; Rohde C; Janssen M; Liebers N; Proynova R; Weinhold N; Raab MS; Goldschmidt H; Besenbeck B; Pavel P; Laier S; Trumpp A; Dietrich S; Vassiliou GS; Müller-Tidow C
Haematologica; 2023 Dec; 108(12):3308-3320. PubMed ID: 37381752
[TBL] [Abstract][Full Text] [Related]
9. PPM1D Knockdown Suppresses Cell Proliferation, Promotes Cell Apoptosis, and Activates p38 MAPK/p53 Signaling Pathway in Acute Myeloid Leukemia.
Li B; Hu J; He D; Chen Q; Liu S; Zhu X; Yu M
Technol Cancer Res Treat; 2020; 19():1533033820942312. PubMed ID: 32691668
[TBL] [Abstract][Full Text] [Related]
10.
Kahn JD; Miller PG; Silver AJ; Sellar RS; Bhatt S; Gibson C; McConkey M; Adams D; Mar B; Mertins P; Fereshetian S; Krug K; Zhu H; Letai A; Carr SA; Doench J; Jaiswal S; Ebert BL
Blood; 2018 Sep; 132(11):1095-1105. PubMed ID: 29954749
[TBL] [Abstract][Full Text] [Related]
11. Environmental influences on clonal hematopoiesis.
King KY; Huang Y; Nakada D; Goodell MA
Exp Hematol; 2020 Mar; 83():66-73. PubMed ID: 31893524
[TBL] [Abstract][Full Text] [Related]
12. Acute myeloid leukemia derived from lympho-myeloid clonal hematopoiesis.
Thol F; Klesse S; Köhler L; Gabdoulline R; Kloos A; Liebich A; Wichmann M; Chaturvedi A; Fabisch J; Gaidzik VI; Paschka P; Bullinger L; Bug G; Serve H; Göhring G; Schlegelberger B; Lübbert M; Kirchner H; Wattad M; Kraemer D; Hertenstein B; Heil G; Fiedler W; Krauter J; Schlenk RF; Döhner K; Döhner H; Ganser A; Heuser M
Leukemia; 2017 Jun; 31(6):1286-1295. PubMed ID: 27881874
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory cytokines promote clonal hematopoiesis with specific mutations in ulcerative colitis patients.
Zhang CRC; Nix D; Gregory M; Ciorba MA; Ostrander EL; Newberry RD; Spencer DH; Challen GA
Exp Hematol; 2019 Dec; 80():36-41.e3. PubMed ID: 31812712
[TBL] [Abstract][Full Text] [Related]
14. Targeting Immune Signaling Pathways in Clonal Hematopoiesis.
Azrakhsh NA; Mensah-Glanowska P; Sand K; Kittang AO
Curr Med Chem; 2019; 26(28):5262-5277. PubMed ID: 30907306
[TBL] [Abstract][Full Text] [Related]
15. Low-Frequency
Seipel K; Frey M; Nilius H; Akhoundova D; Banz Y; Bacher U; Pabst T
Curr Oncol; 2023 Dec; 30(12):10463-10476. PubMed ID: 38132396
[TBL] [Abstract][Full Text] [Related]
16. Somatic mosaic truncating mutations of PPM1D in blood can result from expansion of a mutant clone under selective pressure of chemotherapy.
Kim B; Won D; Lee ST; Choi JR
PLoS One; 2019; 14(6):e0217521. PubMed ID: 31242196
[TBL] [Abstract][Full Text] [Related]
17. Clonal Hematopoiesis and therapy related MDS/AML.
Desai P; Roboz GJ
Best Pract Res Clin Haematol; 2019 Mar; 32(1):13-23. PubMed ID: 30927970
[TBL] [Abstract][Full Text] [Related]
18. How predictive is the finding of clonal hematopoiesis for the development of myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML)?
Steensma DP
Best Pract Res Clin Haematol; 2021 Dec; 34(4):101327. PubMed ID: 34865699
[TBL] [Abstract][Full Text] [Related]
19. Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly.
Zink F; Stacey SN; Norddahl GL; Frigge ML; Magnusson OT; Jonsdottir I; Thorgeirsson TE; Sigurdsson A; Gudjonsson SA; Gudmundsson J; Jonasson JG; Tryggvadottir L; Jonsson T; Helgason A; Gylfason A; Sulem P; Rafnar T; Thorsteinsdottir U; Gudbjartsson DF; Masson G; Kong A; Stefansson K
Blood; 2017 Aug; 130(6):742-752. PubMed ID: 28483762
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of C-terminal truncated PPM1D enhances the effect of doxorubicin on cell viability in human colorectal carcinoma cell line.
Kozakai Y; Kamada R; Kiyota Y; Yoshimura F; Tanino K; Sakaguchi K
Bioorg Med Chem Lett; 2014 Dec; 24(24):5593-5596. PubMed ID: 25466181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
